Is It Possible to Predict False-Positive Exercise Stress Echocardiography Results by Measuring the Left Atrial

Andrea Sonaglioni1, Gian Luigi Nicolosi2, Michele Lombardo1

  • 1Cardiology, MultiMedica Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Milan, ITA.

Cureus
|February 12, 2024
PubMed

Insights

Left atrial antero-posterior diameter adjusted for chest wall dimensions can help identify patients with a low probability of coronary artery disease (CAD). This screening method shows high sensitivity and specificity for predicting false-positive exercise stress echocardiography results.

Area of Science:

  • Cardiology
  • Diagnostic Imaging
  • Echocardiography

Background:

  • Left atrial (LA) size is a known prognostic factor in coronary artery disease (CAD).
  • Previous studies have not evaluated LA antero-posterior (A-P) diameter for screening low-probability CAD patients.
  • This study investigates LA A-P diameter adjusted for thoracic dimensions to predict false-positive (FP) exercise stress echocardiography (ESE) results.

Purpose of the Study:

  • To assess the influence of LA A-P diameter adjusted for A-P thoracic diameter on FP-ESE occurrence.
  • To determine if this ratio can serve as a screening tool for identifying individuals with a low probability of obstructive CAD.

Main Methods:

  • Retrospective analysis of 160 patients with suspected CAD and positive ESE undergoing coronary angiography.
  • Assessment of LA A-P diameter/A-P thoracic diameter ratio and resting transthoracic echocardiography.
  • Primary endpoint: FP-ESE, defined as positive ESE without obstructive CAD (≥70% stenosis).

Main Results:

  • 19.4% of patients (31/160) had FP-ESE.
  • LA A-P diameter/A-P thoracic diameter ratio showed a strong inverse correlation with FP-ESE (OR 0.42).
  • A ratio ≤0.25 demonstrated 100% sensitivity and 85% specificity for predicting FP-ESE (AUC=0.94).

Conclusions:

  • Echocardiographic LA A-P diameter adjusted for thoracic diameter is a valuable tool.
  • This measurement can help identify patients at lower risk of obstructive CAD among those with suspected CAD.
  • It aids in predicting false-positive ESE results, potentially reducing unnecessary invasive procedures.
Abstract